STOCK TITAN

Global Medical Stock Price, News & Analysis

GMRE NYSE

Welcome to our dedicated page for Global Medical news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical stock.

Global Medical REIT Inc. (GMRE) provides essential healthcare infrastructure through its portfolio of specialized medical facilities. This news hub offers investors and industry professionals centralized access to official announcements and market developments.

Track critical updates including property acquisitions, lease agreements with healthcare providers, and financial performance reports. Our curated collection ensures timely access to strategic partnerships, portfolio expansions, and operational milestones that shape this healthcare REIT's trajectory.

All content undergoes strict verification to maintain accuracy and relevance. Users benefit from comprehensive coverage of GMRE's unique position in medical real estate, including its focus on triple-net lease structures and secondary market specialization.

Bookmark this page for efficient monitoring of GMRE's evolving role in healthcare property markets. Combine regular visits with professional financial analysis when making informed decisions about this niche REIT investment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.09%
Tags
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) announced its plan to release first quarter 2023 financial results after market close on May 3, 2023. The company will hold a conference call on May 4, 2023, at 9:00 a.m. Eastern Time to discuss these results, hosted by CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Interested participants can access the call via a live webcast or through dial-in numbers for both US and international participants. A replay will be available starting at 12:00 p.m. Eastern Time on May 4, through midnight Eastern Time on May 18, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
-
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) announced its 2023 first quarter cash dividends for common and preferred shares. The common cash dividend is set at $0.21 per share, payable on April 11, 2023, to stockholders of record as of March 24, 2023. Additionally, the Series A preferred dividend is $0.46875 per share, to be paid on May 1, 2023, for shareholders on record as of April 15, 2023. This reflects the company's ongoing commitment to return value to shareholders through consistent dividends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
dividends
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) reported its financial results for 2022, revealing a 19.6% year-over-year increase in total revenue to $36.3 million in Q4 and $137.3 million for the year. Net income attributable to common stockholders for Q4 was $0.4 million ($0.01 per diluted share) compared to $3.8 million ($0.06 per diluted share) in the prior year. Full-year net income rose to $13.3 million ($0.20 per share) versus $11.8 million ($0.19 per share) previously. The company completed 14 acquisitions totaling $149 million. Rental revenue increased 19.7% to $36.3 million in Q4, despite total expenses climbing to $34.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.29%
Tags
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) will release its fourth quarter and year-end 2022 financial results on February 28, 2023, after market close. A conference call to discuss these results is scheduled for March 1, 2023, at 9:00 a.m. ET. The call will feature key executives including Chairman and CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the call via a live webcast on the Company’s website, with a replay available from 12:00 p.m. ET on March 1 until midnight on March 15, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) recently updated its shareholders on the federal income tax treatment of the dividends paid in 2022. The relevant information has been made available on the Company's website. Shareholders are advised to review their 2022 Forms 1099 and consult with tax advisors regarding their specific tax implications. GMRE is a net-lease medical office REIT that focuses on acquiring specialized healthcare facilities and leasing them to major healthcare systems and physician groups.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
dividends
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) announced that Pipeline Health will assume its leases at the White Rock Medical Center in Dallas as part of its bankruptcy reorganization. The new lease structure will not affect cash rents, rental rates per square foot, or lease terms. Proposed amendments allow GMRE to provide up to $3.8 million for capital expenditures, with $3.1 million expected to increase future rents. Pipeline must also pay any pre-petition rents owed as of October 2022. The outcome of this bankruptcy process is seen as favorable for GMRE, reinforcing its investment strategy in the Dallas market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
none
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) announced its fourth-quarter 2022 dividends, declaring a cash dividend of $0.21 per common share, payable on January 9, 2023, to shareholders of record as of December 22, 2022. Additionally, a quarterly cash dividend of $0.46875 per share on its Series A Preferred Stock will be paid on January 31, 2023, to preferred stockholders of record as of January 15, 2023. This announcement signals the company's ongoing commitment to returning value to its shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.41%
Tags
dividends
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) invested $51 million in medical real estate during Q3 2022, raising its total investments to $149 million for the year. The company achieved a net income of $8.1 million ($0.12 per diluted share), up from $3.7 million ($0.06) YoY. Revenue increased 18.1% to $35.4 million, driven by acquisitions. The company secured a $150 million term loan, locking in 80% of its debt at fixed rates. Occupancy stands at 97%, reflecting portfolio strength. Dividends for the third quarter were declared at $0.21 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) announced it will release its third quarter 2022 financial results on November 2, 2022, after the market closes. A conference call to discuss these results is scheduled for November 3, 2022, at 9:00 a.m. Eastern Time. The call will feature key executives including Jeffrey Busch, Robert Kiernan, and Alfonzo Leon. Investors can access the call via a live webcast or by dialing in. Replay options will be available post-call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.79%
Tags

FAQ

What is the current stock price of Global Medical (GMRE)?

The current stock price of Global Medical (GMRE) is $6.28 as of June 16, 2025.

What is the market cap of Global Medical (GMRE)?

The market cap of Global Medical (GMRE) is approximately 422.7M.
Global Medical

NYSE:GMRE

GMRE Rankings

GMRE Stock Data

422.67M
63.10M
5.65%
63.7%
2.01%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
BETHESDA